【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Myelofibrosis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Myelofibrosis 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Myelofibrosis Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Incyte Corporation 33
Clinical Trial Overview of Incyte Corporation 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
S*BIO Pte Ltd 36
Clinical Trial Overview of S*BIO Pte Ltd 36
Novartis Pharmaceuticals Corporation 37
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Celgene Corporation 39
Clinical Trial Overview of Celgene Corporation 39
Astex Therapeutics Limited 40
Clinical Trial Overview of Astex Therapeutics Limited 40
Cell Therapeutics, Inc. 41
Clinical Trial Overview of Cell Therapeutics, Inc. 41
Gemin X Pharmaceuticals 42
Clinical Trial Overview of Gemin X Pharmaceuticals 42
Luitpold Pharmaceuticals, Inc. 43
Clinical Trial Overview of Luitpold Pharmaceuticals, Inc. 43
Geron Corporation 44
Clinical Trial Overview of Geron Corporation 44
Promedior, Inc. 45
Clinical Trial Overview of Promedior, Inc. 45
Threshold Pharmaceuticals, Inc. 46
Clinical Trial Overview of Threshold Pharmaceuticals, Inc. 46
JW Pharmaceutical Corporation 47
Clinical Trial Overview of JW Pharmaceutical Corporation 47
Pfizer Inc. 48
Clinical Trial Overview of Pfizer Inc. 48
Millennium Pharmaceuticals, Inc. 49
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 49
YM BioSciences Inc. 50
Clinical Trial Overview of YM BioSciences Inc. 50
Infinity Pharmaceuticals, Inc. 51
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 51
Gilead Sciences, Inc. 52
Clinical Trial Overview of Gilead Sciences, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
The University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 53
National Cancer Institute 54
Clinical Trial Overview of National Cancer Institute 54
Mount Sinai School of Medicine 55
Clinical Trial Overview of Mount Sinai School of Medicine 55
Fred Hutchinson Cancer Research Center 56
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 56
Mayo Clinic 57
Clinical Trial Overview of Mayo Clinic 57
Roswell Park Cancer Institute 58
Clinical Trial Overview of Roswell Park Cancer Institute 58
Memorial Sloan Kettering Cancer Center 59
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 59
The University of Utah 60
Clinical Trial Overview of The University of Utah 60
Massachusetts General Hospital 61
Clinical Trial Overview of Massachusetts General Hospital 61
Children’s Oncology Group 62
Clinical Trial Overview of Children’s Oncology Group 62
Thomas Jefferson University 63
Clinical Trial Overview of Thomas Jefferson University 63
Barbara Ann Karmanos Cancer Institute 64
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 64
Weill Cornell Medical College 65
Clinical Trial Overview of Weill Cornell Medical College 65
University of Ulm 66
Clinical Trial Overview of University of Ulm 66
Myeloproliferative Disorders-Research Consortium 67
Clinical Trial Overview of Myeloproliferative Disorders-Research Consortium 67
National Human Genome Research Institute 68
Clinical Trial Overview of National Human Genome Research Institute 68
City of Hope National Medical Center 69
Clinical Trial Overview of City of Hope National Medical Center 69
Gruppo Italiano Trapianto di Midollo Osseo 70
Clinical Trial Overview of Gruppo Italiano Trapianto di Midollo Osseo 70
Indiana University School of Medicine 71
Clinical Trial Overview of Indiana University School of Medicine 71
Odense University Hospital 72
Clinical Trial Overview of Odense University Hospital 72
Five Key Clinical Profiles 73
Appendix 154
Abbreviations 154
Definitions 154
Research Methodology 155
Secondary Research 155
About GlobalData 156
Contact Us 156
Disclaimer 156
Source 156
【レポート販売概要】
■ タイトル：Myelofibrosis：グローバル臨床試験レビューH2, 2013■ 英文：Myelofibrosis Global Clinical Trials Review, H2, 2013
■ 発行日：2013年7月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161499
■ 調査対象地域：グローバル
- 世界の心血管モニタリング装置開発動向：医療機器パイプライン分析2015Cardiovascular Monitoring Devices - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Cardiovascular Monitoring Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiovascular Monitoring Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the …
- 白内障(Cataract)：世界の治験レビュー（2015年上半期版）Cataract Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H1, 2015" provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe …
- 診断用ウェアラブル医療機器の世界市場2016-2020About the Diagnostic Wearable Medical Devices Market Diagnostic wearable medical devices are used to monitor, control, and track an individual's vital signs at regular intervals. These devices are connected to an individual’s body for the measurement of certain physiological information. They are available in the form of eyeglasses, watch, clothing, jewelry, and contact lenses. Diagnostic wearable …
- Itochu Corporation：石油・ガスバリューチェーン分析レポート2013Itochu Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Itochu Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Itochu Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- アテローム切除装置の世界市場分析：用途別（方向性アテローム切除術、回転アテローム切除術、眼窩アテローム切除術、レーザーアテローム切除術）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）、セグメント予測、2014-2025The global atherectomy devices market is expected to reach USD 894.69 million by 2025, based on a new report by Grand View Research, Inc. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease. New technologies and product approvals are expected to boost the market for orbital a …
- United KingdomのCopper Tubes and Pipes市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of United Kingdom and its perspectives on the global market for copper tubes and pipes. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on copper tubes and pipes export/import operations in United Kingdom. The 2002-2 …
- 世界における末梢経管形成バルーンの製品パイプライン動向2015Peripheral Transluminal Angioplasty Balloons - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Peripheral Transluminal Angioplasty Balloons - Pipeline Review, 2015" provides an overview of Peripheral Transluminal Angioplasty (PTA) Balloons currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the …
- ICT調達動向：銀行部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which retail banks select their ICT providers as well as the roles which have influence while making ICT purchasing decisions. What is the current market landscape and what is changing? Retail banks have an optimistic approach towards IT investments, and their preference towards hosted services is slowly gaining traction. What are the key dr …
- 世界におけるOX-40アゴニストのパイプライン分析2015Summary DelveInsight’s, OX-40 Antagonist- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the OX-40 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The OX-40 AgonistReport helps to identify emerging players with potentially stron …
- 食用潤滑油の世界市場：鉱物油、化学合成油、バイオ潤滑油Food grade lubricants are permitted for possible incidental contact with food products. The lubricants based on ingredients used are categorized as H1 (food grade lubricants, permitted for incidental contact), H2 (lubricants not permitted to have incidental contact), and H3 (soluble oils). The certification for this categorization is provided by organizations such as NSF International. Similarly, …
- IoTセンサーの世界市場予測（～2023年）：圧力、温度、湿度、磁力計、ジャイロスコープ、加速度計、画像、慣性“IoT sensors market to grow at 33.60% CAGR during forecast period”The IoT sensors market is expected to be valued at USD 5.28 by 2018 and is projected to reach USD 22.48 billion by 2023, at a CAGR of 33.60% between 2018 and 2023. The growth of the IoT sensors market can be attributed to the increased use of sensors in IoT devices and other applications owing to their reduction in size, plummeting …
- 世界のデジタルコンテンツ市場動向（2012-2016）TechNavio's analysts forecast the Global Digital Content market to grow at a CAGR of 11.71 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing numbers of smartphones and tablets. The Global Digital Content market has also been witnessing an increase in the adoption of cloud services. However, the growing privacy concerns could pose a challeng …
- プログラマティック広告支出の世界市場2016-2020About Programmatic Advertising Spending Programmatic advertising aids advertisers to target a specific audience based on their advertising pattern. The process takes no more than 0.2 seconds. When a user clicks on a URL, a publisher’s content loads in the browser. The publisher may find information of the user in its data management software. The publisher sends the available information to its ad …
- 非アルコール性脂肪肝炎(NASH)：市場機会分析及び予測（～2018）OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Summary GlobalData has released its new Opportunity Analyzer report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update”. The NASH market is currently deserted and awaits its first NASH-specific therapy …
- 自動車カーテンエアバッグの世界市場2016-2020About Automotive Curtain Airbags Curtain airbags have been developed as a result of the growing focus on customer safety by original equipment manufacturers (OEMs), regulators, and customers themselves. Curtain airbags are gaining market traction and should represent a standard automotive safety feature in the future, especially in passenger cars. Sensors trigger the deployment of curtain airbags …
